Merck says Keytruda injection is on par with intravenous version approved in trial

Merck said on Tuesday that a study showed its injectable version of the cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment, likely making…

WeiterlesenMerck says Keytruda injection is on par with intravenous version approved in trial